Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1

Conditions

Glioblastoma 13Brain Neoplasms 12Neuroblastoma 11Gliosarcoma 7Astrocytoma 7Oligodendroglioma 5Glioma 5Medulloblastoma 4Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Wilms Tumor 2Spinal Cord Neoplasms 2Rhabdoid Tumor 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Optic Nerve Glioma 2Lung Neoplasms 2Familial ependymoma 2Diffuse Intrinsic Pontine Glioma 2Dendritic Cell Sarcoma, Interdigitating 2Choroid Plexus Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Cyclophosphamide 14Etoposide 12Temozolomide 10Carboplatin 9Granulocyte Colony-Stimulating Factor 8Filgrastim 8Vincristine 7etoposide phosphate 6X-Rays 6Thiotepa 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cisplatin 6Topotecan 5Specimen Handling 5Radiotherapy 5Nuclear Medicine Department, Hospital 5Methotrexate 5fludarabine 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mesna 4Melphalan 4Biopsy 4palbociclib 3Sirolimus 3Irinotecan 3Ifosfamide 3Busulfan 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Vorinostat × CNS × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT01076530 2013-05-03

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

National Cancer Institute (NCI)

Phase 1 Completed
27 enrolled
CNSEndocrine

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Paraganglioma, Extra-Adrenal, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡